|
|
Featuring: Ali Shilatifard, PhD, Milan Mrksich, PhD, Lu Wang, PhD
A team of Northwestern Medicine scientists led by Ali Shilatifard, PhD, the Robert Francis Furchgott Professor and chair of Biochemistry and Molecular Genetics, has identified the molecular mechanisms of ASXL1 mutations involved in leukemia pathogenesis, according to a study published in Nature Cancer.
“This is first inhibitor can benefit the treatment of leukemia patients with ASXL1 mutations,” said Lu Wang, PhD, assistant professor of Biochemistry and Molecular Genetics and lead author of the study. |
February 2022 January 2022 December 2021 November 2021 October 2021 |
About Us Terms of Use Privacy Policy How to Vote for U.S. News & World Report Best Hospitals
© 2025 Northwestern Medicine® and Northwestern Memorial HealthCare. Northwestern Medicine® is a trademark of Northwestern Memorial HealthCare, used by Northwestern University |